TherapeuticsMD (TXMD) Interest Expenses (2010 - 2026)
TherapeuticsMD's (TXMD) quarterly Interest Expenses came in at $1.4 million in Q1 2026, up 257.03% YoY from $384000.0 in Q1 2025, and up 137000.0% on a QoQ basis from $1000.0 in Q4 2025.
TherapeuticsMD (TXMD) Interest Expenses (2010 - 2026) Analysis & Trends
TherapeuticsMD (TXMD) has 17 years of Interest Expenses data on file, last reported at $1.4 million in Q1 2026.
- Quarterly Interest Expenses rose 257.03% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 257.03% YoY) and the FY2025 annual result came in at $1.4 million, down 99.27% from the prior year.
- Interest Expenses grew to $1.4 million in Q1 2026, from $1000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $22.1 million in Q1 2022 to a low of $1000.0 in Q4 2025.
- A 5-year average of $2.6 million and a median of $438000.0 in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2023 — Interest Expenses slumped 98.02% — and 2024, when it soared 501.37%.
- Tracing TXMD's Interest Expenses over 5 years: stood at $200000.0 in 2022, then plunged by 74.2% to $51600.0 in 2023, then tumbled by 96.12% to $2000.0 in 2024, then slumped by 50.0% to $1000.0 in 2025, then soared by 137000.0% to $1.4 million in 2026.
- The last three Interest Expenses figures came in at $1.4 million (Q1 2026), $1000.0 (Q4 2025), and $384000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.67 Mn | 14.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 383,000.00 |
| Jun 30, 2026 | 383,000.00 |
| Mar 31, 2026 | 1.37 Mn |
| Mar 31, 2026 | 1.37 Mn |
| Dec 31, 2025 | 1,000.00 |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 384,000.00 |
| Sep 30, 2025 | 384,000.00 |
| Jun 30, 2025 | 384,000.00 |
| Jun 30, 2025 | 384,000.00 |
| Mar 31, 2025 | 384,000.00 |
| Mar 31, 2025 | 384,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 2.16 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 384,000.00 |
| Jun 30, 2024 | 384,000.00 |
| Mar 31, 2024 | 2.63 Mn |
| Mar 31, 2024 | 2.63 Mn |